In my earlier post, i have posted a news regarding RNAi related patent granted to Benitec company. In the line of same field of RNAi, Tekmira has also received three US patents related to lipid nanoparticle technology, which will be useful in delivering nucleic acid drugs, including small interfering RNA (siRNA).
Number of these three patentas are US7745651, US7799565, US7803397. These new patents cover key components of our LNP technology, which is already well validated in preclinical studies and is currently part of multiple clinical development programs sponsored by Tekmira and Tekmira’s partners.
Tekmira is a biopharmaceutical company and enagaged in research and development in the field of RNAi and its delivery by lipid nanoparticle technology.
(Source: Tekmira news release)
Showing posts with label RNAi. Show all posts
Showing posts with label RNAi. Show all posts
Tuesday, October 12, 2010
Wednesday, October 6, 2010
RNAi Expression construct patent for Benitec Ltd
Benitec Ltd, a specialized in RNA interference (RNAi) technology got a patent grant at USPTO for its "RNAi Expression Constructs". The granted US Patent having no. 7803611 is related to RNAi costruct using single promoter for targeting hepatitis C virus to inhibit the level of hepatitis C virus in cells, tissues and organs.
Further the USPTO has also granted 925 days of patent term extension against delay in the examination activity at USPTO.
(Source: Pharmabiz)
Further the USPTO has also granted 925 days of patent term extension against delay in the examination activity at USPTO.
(Source: Pharmabiz)
Subscribe to:
Posts (Atom)